U.S. Auto Stock News

NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Biopharma And Battery Growth With New Analytical Platforms

Waters Corporation (NYSE:WAT) has launched new BioResolve and GTxResolve Columns aimed at speeding impurity analysis in biopharmaceutical workflows. The company introduced two mass spectrometry platforms, the Cyclic IMS P20 and Xevo MRT P10, designed to increase speed, sensitivity, and multiomics capabilities. Waters also released a new Coin Cell DSC instrument focused on safer battery development and testing. Waters, known for its analytical instruments and consumables, is leaning into...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is New AI Foundry Deal Flow Altering The Investment Case For Intel’s Dual Role (INTC)?

In early June 2026, Cadence Design Systems announced an expanded multi‑year collaboration with Intel Foundry on Design Technology Co‑Optimization for Intel’s 14A process, while Hitachi and Phison separately unveiled new partnerships with Intel spanning foundry tools, quantum computing, physical AI, and enabling larger AI models on Intel-powered PCs. Taken together with a large 2028 Google TPU manufacturing order and new rackscale AI and Xeon 6+ launches, these alliances strengthen Intel’s...
NYSE:VST
NYSE:VSTRenewable Energy

Will Helix AI Data Center Power Deal Redefine Vistra's (VST) Narrative in the AI Era?

KKR, Kuwait Investment Authority, Nvidia, and Vistra recently launched Helix Digital Infrastructure, a more than US$10.00 billion AI data center venture that designates Vistra as its preferred power provider for hyperscale facilities. This role anchors Vistra at the center of coordinating large-scale, long-duration power supply for AI infrastructure, tying its generation fleet directly to the energy-hungry buildout of next-generation data centers. We’ll now examine how Vistra’s role as...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Stock After 21% Year-To-Date Slide Is There An Opportunity Now

If you are wondering whether ResMed at around US$192 per share offers value or just more volatility, the starting point is understanding what the current price actually reflects. The stock is down 1.0% over the past week, 5.6% over the past month, and 21.4% year to date, with a 23.0% decline over the last year and 16.4% over five years, which may change how investors are thinking about both risk and opportunity. Much of the recent conversation around ResMed has focused on how the company is...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool (WHR) Stock Valuation Revisited After Mixed Short And Long Term Returns

Whirlpool (WHR) has drawn fresh attention after recent share performance data showed mixed returns, including gains over the past week and month alongside declines over the past 3 months and year to date. See our latest analysis for Whirlpool. At a share price of US$42.41, Whirlpool’s recent performance has been mixed, with short term momentum improving, such as a 7 day share price return of 6.02%, against a much weaker multi year total shareholder return, including a 5 year total shareholder...
NYSE:FUL
NYSE:FULChemicals

Does H.B. Fuller’s (FUL) 57-Year Dividend Streak Reveal Its True Capital Return Priorities?

In recent days, commentary around H.B. Fuller has highlighted its 57-year dividend growth record and reputation as a leading global adhesives manufacturer, with some analysts arguing that the shares appear materially undervalued relative to the company’s long-term fundamentals. This focus on dividend durability and perceived undervaluation has reinforced the view that H.B. Fuller’s capital return discipline is a core pillar of its investment appeal. Against that backdrop, we’ll explore how...
NYSE:PSN
NYSE:PSNProfessional Services

Parsons (PSN) Stock After New Air Force GARDEM Contracts And AI Counter Drone Trial

Parsons (PSN) stock is drawing fresh attention after a series of U.S. Air Force Research Laboratory contracts tied to the GARDEM 2 program and a successful AI-enabled counter drone systems demonstration in operational conditions. See our latest analysis for Parsons. Those contract wins and AI-enabled defense milestones come as Parsons’ 1 month share price return of 8.69% contrasts with a year to date share price decline of 7.92%. Over the same period, the 1 year total shareholder return has...
NYSE:WS
NYSE:WSMetals and Mining

Should Worthington Steel’s GM Honors Reshape How Investors View Its Auto Partnerships and Pricing Power (WS)?

Worthington Steel, Inc. was recently named a GM Supplier of the Year winner in General Motors' 34th annual Supplier of the Year awards, marking its fifth recognition since 2020 and third consecutive win. This continued acknowledgement from a major global automaker underscores Worthington Steel’s ongoing role in supporting critical automotive supply chains and innovation initiatives. We’ll now examine how Worthington Steel’s repeated GM Supplier of the Year recognition might influence its...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Refocuses On U.S. AI Teams As India Exit Reshapes Risks

Opendoor Technologies is closing its India operations to centralize work in the U.S. The company plans to build AI native teams in the U.S., reshaping how it allocates global resources. This shift reflects how AI is influencing both product workflows and traditional outsourcing models. For investors tracking NasdaqGS:OPEN, this move comes as the stock trades around $4.47 and has had a very large 1 year return, while still being down 73.4% over 5 years and 26.4% year to date. The decision to...
NYSE:ABT
NYSE:ABTMedical Equipment

Abbott Laboratories (ABT) Stock Valuation Check After Recent Mixed Performance

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with the stock edging up about 0.5% in the latest session and showing a gain over the past month but declines over the past 3 months and year to date. See our latest analysis for Abbott Laboratories. The latest moves come against a weak backdrop, with the share price down about 17% over the past 90 days and the 1 year total shareholder return declining roughly 33%. As a result, recent momentum...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Court Win Lifts Clover Health Star Rating And Future Revenue Potential

Clover Health Investments (NasdaqGS:CLOV) secured a court ruling requiring the Centers for Medicare & Medicaid Services to recalculate its 2026 Medicare Star Rating. The US District Court decision results in an upgrade for Clover Health's main PPO plan from 3.5 to 4.5 stars. The higher rating is expected to increase future CMS bonus payments tied to that plan's performance. The ruling reverses a prior downgrade and strengthens Clover Health's position within the Medicare Advantage...
NasdaqGS:STX
NasdaqGS:STXTech

Seagate Capacity Lock In Resets Growth Outlook And Valuation Debate

Seagate Technology Holdings (NasdaqGS:STX) has secured near-full allocation of its nearline hard drive capacity through calendar 2027. The long term commitments are backed by multi year purchase agreements with key customers. Management has raised its annual revenue growth target to at least 20% based on this contracted demand. For investors watching Seagate at a share price of $868.09, this capacity lock in comes after a period of very strong stock performance, including a return of 201.9%...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

US Stock Market Today: S&P 500 Futures Rise As Energy Inflation Tests Fed Patience

The Morning Bull - US Market Morning Update Friday, Jun, 12 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up around 0.8%, as investors weigh stubborn energy driven inflation against hopes the Federal Reserve can stay patient on interest rates. May consumer prices in the US rose 0.5% in a single month, with gasoline up 7%, which keeps the pressure on household budgets and mortgage rates, now at 6.6%. At the same time, producer prices for May are expected...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum Targets Near Packaged Optics As Next AI Data Center Catalyst

Lumentum Holdings (NasdaqGS:LITE) CEO highlighted near-packaged optics, or NPO, as a major new growth driver for the company. Management indicated that NPO could become a larger opportunity than the current focus on co-packaged optics, or CPO. The CEO pointed to a potentially meaningful impact from NPO beginning in fiscal 2027 to 2028. Lumentum operates in optical and photonics technologies that sit inside the broader semiconductor and AI infrastructure supply chain. As data centers scale...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Stock Valuation Update After Strong Recent Momentum

Axsome Therapeutics (AXSM) has drawn attention after recent trading, with the stock closing at US$253.77. Investors are weighing this move against the company’s central nervous system focused drug portfolio and ongoing clinical programs. See our latest analysis for Axsome Therapeutics. The recent 3.02% 1 day share price return, along with a 62.59% 90 day share price return and 138.84% 1 year total shareholder return, points to strong momentum as investors reassess Axsome Therapeutics’ CNS...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Stock After 27% Monthly Drop And Strong Multi‑Year Rally

If you are wondering whether Hecla Mining's current share price offers value or is running ahead of itself, the next sections break down what the numbers actually say about the stock. The share price closed at US$14.99, with the stock down 10.9% over the past week and 27.1% over the past month, although the 1-year return of 150.5% and 3-year return of 190.3% still stand out. These swings in performance have kept Hecla Mining on many investors' watchlists, as the stock has moved sharply both...
NYSE:MCB
NYSE:MCBBanks

Metropolitan Bank Holding (MCB) Stock Valuation Snapshot After Recent Momentum And Growth Expectations

Metropolitan Bank Holding (MCB) has recently drawn investor attention after its stock closed at $96.18, with performance over the past month and past 3 months prompting closer scrutiny of this regional bank. See our latest analysis for Metropolitan Bank Holding. The recent 2.44% 1 day share price return, alongside a 24.96% year to date share price return and a 47.12% 1 year total shareholder return, points to momentum that investors are weighing against the current valuation and risk...
NYSE:GPGI
NYSE:GPGITech

How GPGI’s Nevada Move and New International CCO Could Reshape GPGI (GPGI) Investors’ Outlook

In recent days, GPGI completed its conversion to a Nevada corporation, saw all 2026 annual meeting proposals approved, and CompoSecure appointed Ian Snadden as Chief Commercial Officer, International to lead global sales efforts. Taken together, the governance shift, auditor appointment and new international commercial leadership highlight a corporate focus on legal flexibility and overseas expansion at a time of operational and market challenges. Next, we’ll examine how GPGI’s move to...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck Expands Animal Health Automation And Traceability With TARGAN And Hedera

Merck Animal Health has agreed to acquire TARGAN, a poultry biodevice company focused on high speed gender identification and vaccine delivery. The company is also partnering with the Hashgraph Group to integrate Hedera powered digital product passports with its M-Trust authentication platform. Both moves expand Merck's reach into animal health automation and supply chain traceability tied to new EU transparency rules. For investors following Merck (NYSE:MRK), this news sits alongside a...
NYSE:AMN
NYSE:AMNHealthcare

AMN Healthcare Services (AMN) Stock After 103.6% Yearly Surge Is The Valuation Justified

Wondering whether AMN Healthcare Services at around US$30.79 is offering value right now or just catching your eye after a big move. The stock is up 0.6% over the last week and 4.5% over the past month, with a 103.6% return year to date and a 42.4% gain over the last year, even though the share price has fallen 71.6% over three years and 67.7% over five years. Recent coverage has focused on how AMN Healthcare Services fits into investor interest around healthcare staffing and workforce...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Plug Power’s Margin Repair And Leadership Shift Refocus Investor Attention

Plug Power (NasdaqCM:PLUG) reports sharply improved margins and tighter cost controls, highlighting early signs of an operational turnaround. The company outlines progress on its Project Quantum Leap initiative, targeting leaner operations and better capital discipline. New CEO José Luis Crespo accelerates a shift toward vertical integration, including more in house hydrogen production capacity. Management frames these changes as a structural move toward profitability in Plug Power's...
NYSE:RNST
NYSE:RNSTBanks

Renasant (RNST) Stock Valuation Check After Recent Gains And Merger Expectations

Renasant (RNST) has drawn fresh attention after recent share price moves, with the stock last closing at $42.26. Investors are weighing this performance against the bank's mix of community banking and wealth management operations. See our latest analysis for Renasant. Recent trading has come on the back of a firm run in the share price, with a 30 day share price return of 6.72% feeding into a 19.48% year to date gain and a 20.93% 1 year total shareholder return. This suggests that momentum...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Is Up 6.1% After Early In Vivo CAR-T Data for LB2501 – What's Changed

Legend Biotech recently reported early Phase 1 data for LB2501, an investigational in vivo CD19/CD20 dual-targeting CAR-T therapy in relapsed/refractory B-cell non-Hodgkin lymphoma, showing high response rates, dose-dependent in vivo CAR-T expansion, and a manageable safety profile without lymphodepleting chemotherapy. The ability of LB2501 to generate CAR-T cells directly inside patients from a single off-the-shelf infusion could materially simplify treatment logistics compared with...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Equinix (EQIX) Stock After 36% YTD Rally Is Growth Already Priced In?

This article examines whether Equinix, at around US$1,043 per share, is offering good value or embedding high future expectations, by breaking down what the current price might be implying. Over the past week the stock is down 4.2% and over the past month it is down 3.5%. Year to date it is up 36.5% and over the last year it has returned 19.0%, which naturally raises questions about how much of that performance is already reflected in the price. Over the last three and five years, Equinix...